文献速递消化道肿瘤与早癌炎症性肠病

无癌Lynch综合征携带者与Lynch综合征结直肠癌患者正常结肠黏膜的免疫特征差异

The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients.
PubMed 文献 · Gastroenterology · 2021-12-02

研究量化了Lynch综合征(LS)结直肠癌患者、散发性微卫星不稳定(MSI)和微卫星稳定(MSS)结直肠癌患者及无癌LS携带者远离肿瘤的正常结直肠黏膜中CD3、FOXP3和CD8阳性T细胞,发现LS正常黏膜T细胞密度显著高于非LS对照,基因表达谱可区分有无癌症表现的LS携带者黏膜,CAPP2试验随访显示黏膜T细胞浸润与后续肿瘤发生时间相关。

要点

  • LS携带者无癌时正常结肠黏膜CD3、FOXP3、CD8阳性T细胞密度已显著升高。
  • LS携带者黏膜基因表达谱可区分有无癌症表现者。
  • CAPP2试验中黏膜T细胞浸润与后续肿瘤发生时间相关。

核心结论

  • LS携带者即使无癌也表现黏膜T细胞浸润升高,正常黏膜免疫特征可能是LS携带者肿瘤风险的暂时或永久修饰因素。

研究设计与样本

  • 研究对结直肠癌患者和无癌LS携带者的219、233和201份FFPE正常结肠黏膜组织切片以及26、22和19例LS结直肠癌分别定量CD3、FOXP3和CD8阳性T细胞。
  • 在CAPP2临床试验入组的97份FFPE正常直肠黏膜组织切片独立队列中也定量了CD3阳性T细胞。
  • 使用NanoString nCounter平台在部分样本中分析了770个免疫相关基因的表达。

主要发现

  • LS正常黏膜标本的CD3、FOXP3和CD8阳性T细胞密度显著高于非LS对照标本。
  • 基因表达谱和聚类分析显示,有和无癌症表现的LS携带者黏膜具有不同的免疫特征。
  • CAPP2试验内LS携带者的长期随访发现黏膜T细胞浸润与后续肿瘤发生时间之间存在相关性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Owing to the high load of immunogenic frameshift neoantigens, tumors arising in individuals with Lynch syndrome (LS), the most common inherited colorectal cancer (CRC) syndrome, are characterized by a pronounced immune infiltration. However, the immune status of normal colorectal mucosa in LS is not well characterized. We assessed the immune infiltrate in tumor-distant normal colorectal mucosa from LS CRC patients, sporadic microsatellite-unstable (MSI) and microsatellite-stable (MSS) CRC patients, and cancer-free LS carriers. METHODS: CD3-positive, FOXP3-positive, and CD8-positive T cells were quantified in, respectively, 219, 233, and 201 formalin-fixed paraffin-embedded (FFPE) normal colonic mucosa tissue sections from CRC patients and cancer-free LS carriers and 26, 22, and 19 LS CRCs. CD3-positive T cells were also quantified in an independent cohort of 97 FFPE normal rectal mucosa tissue sections from LS carriers enrolled in the CAPP2 clinical trial. The expression of 770 immune-relevant genes was analyzed in a subset of samples with the use of the NanoString nCounter platform. RESULTS: LS normal mucosa specimens showed significantly elevated CD3-, FOXP3-, and CD8-positive T-cell densities compared with non-LS control specimens. Gene expression profiling and cluster analysis revealed distinct immune profiles in LS carrier mucosa with and without cancer manifestation. Long-term follow-up of LS carriers within the CAPP2 trial found a correlation between mucosal T-cell infiltrate and time to subsequent tumor occurrence. CONCLUSIONS: LS carriers show elevated mucosal T-cell infiltration even in the absence of cancer. The normal mucosa immune profile may be a temporary or permanent tumor risk modifier in LS carriers.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Bohaumilitzky L, Kluck K, Hüneburg R, et al. The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients. Gastroenterology. 2021. PMID: 34863788. doi:10.1053/j.gastro.2021.11.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。